136 related articles for article (PubMed ID: 38160940)
1. Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop.
Yuen KCJ; Ghalib L; Buchfelder M; Hughes J; Langlois F; Molitch ME
Endocr Pract; 2024 Mar; 30(3):282-291. PubMed ID: 38160940
[TBL] [Abstract][Full Text] [Related]
2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.
Sarkar S; Chacko AG; Chacko G
J Clin Neurosci; 2015 Jul; 22(7):1173-7. PubMed ID: 25979255
[TBL] [Abstract][Full Text] [Related]
4. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
5. Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images.
Niu J; Zhang S; Ma S; Diao J; Zhou W; Tian J; Zang Y; Jia W
Eur Radiol; 2019 Mar; 29(3):1625-1634. PubMed ID: 30255254
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.
Kobayashi T
Prog Neurol Surg; 2009; 22():77-95. PubMed ID: 18948721
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
[TBL] [Abstract][Full Text] [Related]
8. Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.
Yao A; Balchandani P; Shrivastava RK
World Neurosurg; 2017 Aug; 104():489-498. PubMed ID: 28461279
[TBL] [Abstract][Full Text] [Related]
9. [Radiological classification of pituitary adenomas].
Edal AL
Ugeskr Laeger; 2001 Aug; 163(33):4349-53. PubMed ID: 11521567
[TBL] [Abstract][Full Text] [Related]
10. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
11. Utility of
Wang Z; Mao Z; Zhang X; He D; Wang X; Du Q; Xiao Z; Zhu D; Zhu Y; Wang H
Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
13. A current perspective of pituitary adenoma MRI characteristics: a review.
Gruppetta M
Expert Rev Endocrinol Metab; 2022 Nov; 17(6):499-511. PubMed ID: 36373167
[TBL] [Abstract][Full Text] [Related]
14. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.
Pangal DJ; Wishart D; Shiroishi MS; Ruzevick J; Carmichael JD; Zada G
Pituitary; 2022 Jun; 25(3):480-485. PubMed ID: 35334028
[TBL] [Abstract][Full Text] [Related]
17. Evolution of postoperative pituitary adenoma resection cavities assessed by magnetic resonance imaging and implications regarding radiotherapy timing and modality.
Farnworth MT; Yuen KCJ; Chapple KM; Matthees NG; White WL; Little AS; Rogers L; Hughes JN
Clin Imaging; 2022 Feb; 82():110-116. PubMed ID: 34801841
[TBL] [Abstract][Full Text] [Related]
18. Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive?
Yokoyama S; Hirano H; Moroki K; Goto M; Imamura S; Kuratsu JI
Neurosurgery; 2001 Oct; 49(4):857-62; discussion 862-3. PubMed ID: 11564246
[TBL] [Abstract][Full Text] [Related]
19. Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas.
Kim JH; Dho YS; Kim YH; Lee JH; Lee JH; Hong AR; Shin CS
J Neurosurg; 2018 Sep; 131(2):500-506. PubMed ID: 30215565
[TBL] [Abstract][Full Text] [Related]
20. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]